Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy (NCT07098169)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the effectiveness of a psychosocial intervention called iTEST for people with psychotic disorders that targets introspective accuracy, or the ability to accurately gauge ones abilities. iTEST combines daily cognitive training on a mobile device with coaching that addresses recovery goals. In this trial, we will randomize people to one of two interventions conditions, iTEST or a control condition that receives coaching and cognitive training that does not emphasize introspective accuracy. Both interventions will take place over 12 weeks and participants will be asked to complete assessments at baseline, 6 weeks, 12 weeks, and 24 weeks. The primary outcome of the study is community functioning. Participants will be from three metropolitan areas: San Diego, Dallas, or Miami.
Who can join: Review the eligibility criteria below.
Location: UC San Diego — San Diego, California
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
- iTEST (BEHAVIORAL)
- Active Control (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- UC San Diego — San Diego, California
- University of Miami — Miami, Florida
- University of Texas at Dallas — Dallas, Texas
📞 Contact the Study Coordinator
Phone: (858) 822-4251
Email: cdepp@ucsd.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Schizophrenia Disorders
- An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia — Bellflower, California
- Visual Perception in Schizophrenia — Rochester, New York
- Brain Stimulation to the Hippocampus in Schizophrenia — Stanford, California
- White Matter Plasticity in Schizophrenia — Catonsville, Maryland
- Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy — Nashville, Tennessee
Explore by condition: All Schizophrenia Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.